AVEO Oncology
MA - BostonBiotechnology
Focus: AVEO Oncology is a small-molecule focused biotechnology company specializing in oncology therapeutics based in Boston. Limited public data suggests a pre-commercial or early-stage biotech operating at modest scale.
Profile data last refreshed 1h ago · AI intelligence enriched 2mo ago
Open Jobs
1+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at AVEO Oncology?
AI assessmentAVEO presents an early-stage oncology opportunity for risk-tolerant professionals seeking hands-on impact, but limited hiring and opaque operations warrant significant diligence before committing.
Why Work Here
- Focused oncology portfolio in high-demand therapeutic area with clear clinical relevance
- Early-stage asset (Atezolizumab in bile duct cancer at Phase 1/2) offers opportunity to shape development strategy
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Atezolizumab
Bile Duct CancerClinical Trials (1)
NCT05000294Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Phase 1/2Help build intelligence for AVEO Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.